178 related articles for article (PubMed ID: 37184054)
21. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
22. Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review.
Cobucci RN; Lima PH; de Souza PC; Costa VV; Cornetta Mda C; Fernandes JV; Gonçalves AK
J Infect Public Health; 2015; 8(1):1-10. PubMed ID: 25294086
[TBL] [Abstract][Full Text] [Related]
23. AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy.
Bower M; Palmieri C; Dhillon T
Curr Opin Infect Dis; 2006 Feb; 19(1):14-9. PubMed ID: 16374212
[TBL] [Abstract][Full Text] [Related]
24. Deaths Attributable to Cancer in the US Human Immunodeficiency Virus Population During 2001-2015.
Horner MJ; Shiels MS; Pfeiffer RM; Engels EA
Clin Infect Dis; 2021 May; 72(9):e224-e231. PubMed ID: 32710777
[TBL] [Abstract][Full Text] [Related]
25. Disparities in human papillomavirus-related cancer incidence and survival among human immunodeficiency virus-infected Hispanics living in the United States.
Ortiz AP; Engels EA; Nogueras-González GM; Colón-López V; Soto-Salgado M; Vargas A; Machin M; Shiels MS
Cancer; 2018 Dec; 124(23):4520-4528. PubMed ID: 30345506
[TBL] [Abstract][Full Text] [Related]
26. Developing clinical strength-of-evidence approach to define HIV-associated malignancies for cancer registration in Kenya.
Korir A; Mauti N; Moats P; Gurka MJ; Mutuma G; Metheny C; Mwamba PM; Oyiro PO; Fisher M; Ayers LW; Rochford R; Mwanda WO; Remick SC
PLoS One; 2014; 9(1):e85881. PubMed ID: 24465764
[TBL] [Abstract][Full Text] [Related]
27. Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS Clinical Trial Group study participants.
Rabkin CS; Testa MA; Huang J; Von Roenn JH
J Acquir Immune Defic Syndr; 1999 Aug; 21 Suppl 1():S31-3. PubMed ID: 10430216
[TBL] [Abstract][Full Text] [Related]
28. Cancer risk in people infected with human immunodeficiency virus in the United States.
Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
[TBL] [Abstract][Full Text] [Related]
29. Risk of other cancers following Kaposi's sarcoma: relation to acquired immunodeficiency syndrome.
Biggar RJ; Curtis RE; Cote TR; Rabkin CS; Melbye M
Am J Epidemiol; 1994 Feb; 139(4):362-8. PubMed ID: 8109570
[TBL] [Abstract][Full Text] [Related]
30. Immune deficiency and risk for malignancy among persons with AIDS.
Mbulaiteye SM; Biggar RJ; Goedert JJ; Engels EA
J Acquir Immune Defic Syndr; 2003 Apr; 32(5):527-33. PubMed ID: 12679705
[TBL] [Abstract][Full Text] [Related]
31. Incidence of lymphomas and other cancers in HIV-infected and HIV-uninfected patients with hemophilia.
Rabkin CS; Hilgartner MW; Hedberg KW; Aledort LM; Hatzakis A; Eichinger S; Eyster ME; White GC; Kessler CM; Lederman MM
JAMA; 1992 Feb; 267(8):1090-4. PubMed ID: 1735926
[TBL] [Abstract][Full Text] [Related]
32. The epidemiology of acquired immunodeficiency syndrome malignancies.
Goedert JJ
Semin Oncol; 2000 Aug; 27(4):390-401. PubMed ID: 10950365
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology of AIDS-related malignancies.
Rabkin CS
Curr Opin Oncol; 1994 Sep; 6(5):492-6. PubMed ID: 7827152
[TBL] [Abstract][Full Text] [Related]
34. A case-control study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda.
Newton R; Ziegler J; Beral V; Mbidde E; Carpenter L; Wabinga H; Mbulaiteye S; Appleby P; Reeves G; Jaffe H;
Int J Cancer; 2001 Jun; 92(5):622-7. PubMed ID: 11340563
[TBL] [Abstract][Full Text] [Related]
35. High Cancer Burden Among Antiretroviral Therapy Users in Malawi: A Record Linkage Study of Observational Human Immunodeficiency Virus Cohorts and Cancer Registry Data.
Horner MJ; Chasimpha S; Spoerri A; Edwards J; Bohlius J; Tweya H; Tembo P; Nkhambule F; Phiri EM; Miller WC; Malisita K; Phiri S; Dzamalala C; Olshan AF; Gopal S
Clin Infect Dis; 2019 Aug; 69(5):829-835. PubMed ID: 30452634
[TBL] [Abstract][Full Text] [Related]
36. Increasing incidence of cancers associated with the human immunodeficiency virus epidemic.
Rabkin CS; Biggar RJ; Horm JW
Int J Cancer; 1991 Mar; 47(5):692-6. PubMed ID: 2004849
[TBL] [Abstract][Full Text] [Related]
37. HIV-related malignancies: community-based study using linkage of cancer registry and HIV registry data.
Cooksley CD; Hwang LY; Waller DK; Ford CE
Int J STD AIDS; 1999 Dec; 10(12):795-802. PubMed ID: 10639060
[TBL] [Abstract][Full Text] [Related]
38. Cancer risk in adolescents and young adults living with HIV in South Africa: a nationwide cohort study.
Ruffieux Y; Dhokotera T; Muchengeti M; Bartels L; Olago V; Bohlius J; Singh E; Egger M; Rohner E
Lancet HIV; 2021 Oct; 8(10):e614-e622. PubMed ID: 34509198
[TBL] [Abstract][Full Text] [Related]
39. Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007.
Shiels MS; Pfeiffer RM; Hall HI; Li J; Goedert JJ; Morton LM; Hartge P; Engels EA
JAMA; 2011 Apr; 305(14):1450-9. PubMed ID: 21486978
[TBL] [Abstract][Full Text] [Related]
40. Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers.
Chaturvedi AK; Mbulaiteye SM; Engels EA
Ann Epidemiol; 2008 Mar; 18(3):230-4. PubMed ID: 18083545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
